Longitudinal Evaluation of Active-Duty Personnel with Accessory Pathways (LEAD-AP)

Active, not recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Cardiac DeathCardiac Death, SuddenWolf Parkinson White Syndrome
Interventions
PROCEDURE

Ablation

Patient treated with an ablation to eliminate the accessory conduction pathway in the heart.

PROCEDURE

Standard of care without ablation

Patient diagnosed with accessory pathway but elected against cardiac ablation as a treatment option at the time of diagnosis.

Trial Locations (1)

92134

Naval Medical Center San Diego, San Diego

All Listed Sponsors
lead

United States Naval Medical Center, San Diego

FED

NCT06798961 - Longitudinal Evaluation of Active-Duty Personnel with Accessory Pathways (LEAD-AP) | Biotech Hunter | Biotech Hunter